LYPD1 and hepatocellular carcinoma: found that ALKBH5-mediated m6A demethylation led to post-transcriptional inhibition of LY6/PLAUR Domain Containing 1 (LYPD1), which inhibited malignant progression of hepatocellular carcinoma (22).